The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Gozellix
Gozetotide · Kit · Telix Innovations SA
NDC 84552-0500-25 · 1 KIT in 1 CARTON * 2.5 mL in 1 VIAL, MULTI-DOSE * 6.4 mL in 1 VIAL, MULTI-DOSE * 2 mL in 1 AMPULE * 1 POWDER, FOR SOLUTION in 1 VIAL, MULTI-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA219592
- TE code
- —
- Approval date
- Mar 20, 2025
- Patents / exclusivity
- 1 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11027031 | Jul 28, 2035 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Gozetotide (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Telix Innovations SA | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Gozellix — NDC 84552-0500-25," retrieved September 3, 2026, https://drugdashboards.com/drug/84552050025.
Free to cite with attribution — see how the data is put together.